| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |